Cost-effectiveness of bevacizumab versus ranibizumab in patients with diabetic macular edema. Analysis from the BRDME study

FBS Grp; M. J. C. Vader; F. D. Verbraak; G. Dijkman; J. M. M. Hooymans; L. I. Los; T. Peto; C. B. Hoyng; R. van Leeuwen; J. R. Vingerling; A. C. Moll; J. J. C. van Lith-Verhoeven; R. O. Schlingemann; M. G. W. Dijkgraaf

Cost-effectiveness of bevacizumab versus ranibizumab in patients with diabetic macular edema. Analysis from the BRDME study

FBS Grp, M. J. C. Vader, F. D. Verbraak, G. Dijkman, J. M. M. Hooymans, L. I. Los, T. Peto, C. B. Hoyng, R. van Leeuwen, J. R. Vingerling, A. C. Moll, J. J. C. van Lith-Verhoeven, R. O. Schlingemann, M. G. W. Dijkgraaf

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	42
Number of pages	1
Journal	Acta ophthalmologica
Volume	98
Publication status	Published - Aug-2020

Handle.net

Persistent link

Cite this

FBS Grp, Vader, M. J. C., Verbraak, F. D., Dijkman, G., Hooymans, J. M. M., Los, L. I., Peto, T., Hoyng, C. B., van Leeuwen, R., Vingerling, J. R., Moll, A. C., van Lith-Verhoeven, J. J. C., Schlingemann, R. O., & Dijkgraaf, M. G. W. (2020). Cost-effectiveness of bevacizumab versus ranibizumab in patients with diabetic macular edema. Analysis from the BRDME study. Acta ophthalmologica, 98, 42.

@article{dd85d94d02d842f7850dd9ae6172fac2,

title = "Cost-effectiveness of bevacizumab versus ranibizumab in patients with diabetic macular edema. Analysis from the BRDME study",

author = "\{FBS Grp\} and Vader, \{M. J. C.\} and Verbraak, \{F. D.\} and G. Dijkman and Hooymans, \{J. M. M.\} and Los, \{L. I.\} and T. Peto and Hoyng, \{C. B.\} and \{van Leeuwen\}, R. and Vingerling, \{J. R.\} and Moll, \{A. C.\} and \{van Lith-Verhoeven\}, \{J. J. C.\} and Schlingemann, \{R. O.\} and Dijkgraaf, \{M. G. W.\}",

year = "2020",

month = aug,

language = "English",

volume = "98",

pages = "42",

journal = "Acta ophthalmologica",

issn = "1755-375X",

publisher = "Wiley",

}

TY - JOUR

T1 - Cost-effectiveness of bevacizumab versus ranibizumab in patients with diabetic macular edema. Analysis from the BRDME study

AU - FBS Grp

AU - Vader, M. J. C.

AU - Verbraak, F. D.

AU - Dijkman, G.

AU - Hooymans, J. M. M.

AU - Los, L. I.

AU - Peto, T.

AU - Hoyng, C. B.

AU - van Leeuwen, R.

AU - Vingerling, J. R.

AU - Moll, A. C.

AU - van Lith-Verhoeven, J. J. C.

AU - Schlingemann, R. O.

AU - Dijkgraaf, M. G. W.

PY - 2020/8

Y1 - 2020/8

M3 - Meeting Abstract

SN - 1755-375X

VL - 98

SP - 42

JO - Acta ophthalmologica

JF - Acta ophthalmologica

ER -